Stada Arzneimittel AG - Company Profile
Powered by 
All the sales intelligence you need on Stada Arzneimittel AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Stada Arzneimittel AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Stada Arzneimittel AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Stada Arzneimittel AG Catalyst Calendar
Proactively evaluate Stada Arzneimittel AG’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Stada Arzneimittel AG Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 30 Jun 2021 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 17 Jun 2021 | Phase III Trial Completion | AIM Foundation; Barts Charity; Barts Health NHS Trust; Cytoplan Ltd; DSM Nutritional Products Ltd; Fischer Family Trust; Hyphens Pharma Pte Ltd; NIHR Clinical Research Network; Pharma Nord (UK) Ltd; Queen Mary University of London; Synergy Biologics Ltd; Thornton & Ross Ltd | - | cholecalciferol | Infectious Disease; Respiratory | Coronavirus Disease 2019 (COVID-19); Respiratory Tract Infections | Clinical Trial Registry |
| 11 May 2021 | Phase III Trial Completion | Stada Arzneimittel AG; Syneos Health Inc; Xbrane Biopharma AB | SYNH; XBRANE | ranibizumab biosimilar | Metabolic Disorders; Ophthalmology | Age Related Macular Degeneration; Diabetic Macular Edema; Diabetic Retinopathy; Macular Degeneration; Wet (Neovascular / Exudative) Macular Degeneration | Clinical Trial Registry |
| 31 Dec 2020 | Phase II Trial Completion | Nizhpharm | - | meloxicam; thiocolchicoside | Central Nervous System | Low Back Pain; Neck Pain (Cervicalgia); Pain | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer